Form 8-K - Current report:
SEC Accession No. 0001477932-19-000004
Filing Date
2019-01-02
Accepted
2019-01-02 16:44:24
Documents
3
Period of Report
2018-11-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K oncx_8k.htm 8-K 15913
2 SECURITIES PURCHASE AGREEMENT oncx_ex101.htm EX-10.1 54382
3 CONVERTIBLE PROMISSORY NOTE oncx_ex102.htm EX-10.2 67743
  Complete submission text file 0001477932-19-000004.txt   139702
Mailing Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014
Business Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014 281-402-3167
Oncolix, Inc. (Filer) CIK: 0001584137 (see all company filings)

EIN.: 463046340 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55545 | Film No.: 19502234
SIC: 2834 Pharmaceutical Preparations